omniture
logo
Search
InventisBio
Media Room

Latest News

rss

InventisBio Announces Positive Phase 2 Study Results for D-2570 (TYK2 Inhibitor) in Patients with Moderate to Severe Plaque Psoriasis

– D-2570 demonstrates robust efficacy and favorable safety profile, achieving skin clearance compar...

2024-12-03 17:44 1827

InventisBio Reported Promising Phase I Study Results of a Novel KRAS G12C Inhibitor D-1553 in Cancer Patients

SHANGHAI, April 11, 2022 /PRNewswire/ -- InventisBio Co., Ltd., a clinical-stage biotech company ba...

2022-04-11 17:37 981